Note: Ingredients listed on restricted chemical lists
EC/CAS
69-72-7
Name of the chemical
Salicylic acid
Concentration
1-2.5
General Information
Revision date
2012-06-15
Product name
Clearasil Ultra Acne Clearing Scrub
1.2.1 Relevant identified uses
Exfoliating scrub space
Icons in SDS
Company Information
company name
Reckitt Benckiser
GHS Information
Signal word
Warnings
Section 2
SECTION 2: Hazards identification
OSHA Regulatory Status space Emergency overview This product is regulated by the US FDA as an over-the-counter, monograph drug. Warnings For external use only. When using this product, avoid contact with the eyes. If product gets into the eyes rinse thoroughly with water. Use with other topical acne medications, at the same time or immediately following use of this product, may increase dryness or irritation of the skin. If this occurs, only one acne medication should be used unless directed by your doctor. Limit use to the face and neck. Stop use and ask a doctor if skin or eye irritation develops. In case of accidental ingestion, get medical help or contact a Poison Control Center immediately. KEEP OUT OF REACH OF CHILDREN. space
Potential Acute Health Effects
space
Principle Routes of Exposure
Eye, Skin contact, Inhalation, Ingestion. space Eyes May cause eye irritation. Skin Unlikely to cause adverse effects. May cause slight skin irritation. Not expected to be a skin sensitizer. space Inhalation Unlikely to cause respiratory effects. space Ingestion Ingestion may cause gastrointestinal irritation. space Target organs Eyes. Respiratory system. space
Potential chronic health
The finished product is not expected to have chronic health effects. space Signs and symptoms Symptoms may include redness, edema, drying, defatting and cracking of the skin. space OSHA Regulatory Status This acne product is in compliance with Title 21 of the Code of Federal Regulations, Part 207 and meets the regulatory requirements outlined in the OTC Monograph under 21 CFR Part 333D. space
Environmental effects
See section 12. .